tradingkey.logo

AtriCure Inc

ATRC
32.860USD
+0.870+2.72%
Cierre 11/11, 16:00ETCotizaciones retrasadas 15 min
1.63BCap. mercado
PérdidaP/E TTM

Más Datos de AtriCure Inc Compañía

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Información de AtriCure Inc

Símbolo de cotizaciónATRC
Nombre de la empresaAtriCure Inc
Fecha de salida a bolsaAug 05, 2005
Director ejecutivoMr. Michael H. (Mike) Carrel, CPA
Número de empleados1300
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 05
Dirección7555 Innovation Way
CiudadMASON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal45040
Teléfono15137554100
Sitio Webhttps://www.atricure.com
Símbolo de cotizaciónATRC
Fecha de salida a bolsaAug 05, 2005
Director ejecutivoMr. Michael H. (Mike) Carrel, CPA

Ejecutivos de AtriCure Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-6.78%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
110.58M
81.23%
Europe
16.13M
11.85%
Asia
7.48M
5.50%
Other international
1.94M
1.42%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.71%
Wellington Management Company, LLP
7.98%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.93%
Hood River Capital Management LLC
6.16%
Otro
62.02%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.71%
Wellington Management Company, LLP
7.98%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.93%
Hood River Capital Management LLC
6.16%
Otro
62.02%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.57%
Investment Advisor/Hedge Fund
40.32%
Hedge Fund
5.89%
Individual Investor
3.50%
Research Firm
1.72%
Pension Fund
0.79%
Bank and Trust
0.64%
Family Office
0.07%
Venture Capital
0.04%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
510
50.67M
101.92%
-9.84M
2025Q2
533
52.65M
105.93%
-5.83M
2025Q1
544
53.44M
107.95%
-4.07M
2024Q4
526
50.00M
102.31%
-11.07M
2024Q3
522
53.78M
110.47%
-8.64M
2024Q2
511
54.11M
111.85%
-4.03M
2024Q1
517
53.02M
109.65%
-1.47M
2023Q4
515
50.20M
105.93%
-1.70M
2023Q3
504
48.87M
103.22%
-3.82M
2023Q2
499
48.88M
103.48%
-3.46M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
4.90M
9.85%
+191.85K
+4.08%
Jun 30, 2025
Wellington Management Company, LLP
3.97M
7.99%
+3.27M
+465.38%
Jun 30, 2025
AllianceBernstein L.P.
3.57M
7.19%
-103.20K
-2.81%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.45M
6.94%
-124.60K
-3.49%
Jun 30, 2025
Hood River Capital Management LLC
3.06M
6.16%
+61.85K
+2.06%
Jun 30, 2025
Macquarie Investment Management
2.50M
5.04%
+66.37K
+2.72%
Jun 30, 2025
Champlain Investment Partners, LLC
2.02M
4.06%
-121.21K
-5.67%
Jun 30, 2025
State Street Investment Management (US)
1.27M
2.56%
-4.56K
-0.36%
Jun 30, 2025
Neuberger Berman, LLC
1.19M
2.39%
+3.67K
+0.31%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.18M
2.38%
+14.58K
+1.25%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.65%
Harbor Human Capital Factor US Small Cap ETF
0.71%
First Trust Small Cap Growth AlphaDEX Fund
0.48%
Invesco NASDAQ Future Gen 200 ETF
0.46%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Fidelity Enhanced Small Cap ETF
0.29%
Franklin US Small Cap Multifactor Index ETF
0.26%
JPMorgan Fundamental Data Science Small Core ETF
0.23%
iShares U.S. Medical Devices ETF
0.21%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.18%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.65%
Harbor Human Capital Factor US Small Cap ETF
Proporción0.71%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.48%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.46%
Amplify Etho Climate Leadership U.S. ETF
Proporción0.3%
Fidelity Enhanced Small Cap ETF
Proporción0.29%
Franklin US Small Cap Multifactor Index ETF
Proporción0.26%
JPMorgan Fundamental Data Science Small Core ETF
Proporción0.23%
iShares U.S. Medical Devices ETF
Proporción0.21%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.18%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI